This WHO country study on counterfeit drugs was one of the components of the WHO project on counterfeit drugs. It was a joint activity between WHO’s Action Programme on Essential Drugs (DAP) and the Division of Drug Management and Policies (DMP), and was launched to obtain independent information on the problem of counterfeit drugs in selected countries and to develop measures for combating pharmaceutical counterfeiting. The Government of Japan financed the project.